Skip to main content
Clinical Trials/NCT00654394
NCT00654394
Completed
Phase 3

Randomized, Double-Blind, Multicenter, Trial to Assess the Effect of High & Low Doses of ZD4522 on Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic Subjects With Asymptomatic Carotid Stenosis After 24 Months of Dosing.

AstraZeneca0 sites200 target enrollmentJanuary 2000

Overview

Phase
Phase 3
Intervention
Rosuvastatin
Conditions
Carotid Artery Stenosis
Sponsor
AstraZeneca
Enrollment
200
Primary Endpoint
Changes in carotid wall volume as measured by MRI scan
Status
Completed
Last Updated
17 years ago

Overview

Brief Summary

The purpose of this study is to examine the changes in the carotid artery when subjects receive high or low doses of rosuvastatin.

Registry
clinicaltrials.gov
Start Date
January 2000
End Date
August 2004
Last Updated
17 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Fasting blood low density lipoprotein cholesterol level as defined by the protocol
  • Diagnosed carotid arterial stenosis

Exclusion Criteria

  • The use of lipid lowering drugs or dietary supplements after Visit
  • Heavy or total occlusion of the carotid artery or recent stroke
  • Uncontrolled hypertension, hypothyroidism, alcohol or drug abuse

Arms & Interventions

1

Intervention: Rosuvastatin

Outcomes

Primary Outcomes

Changes in carotid wall volume as measured by MRI scan

Time Frame: At 40 weeks and 104 weeks

Secondary Outcomes

  • Safety: adverse events & abnormal laboratory markers(2 weekly for first 4 weeks then 4 weekly)
  • Other changes in the structure and composition of the carotid arterial wall as defined in the protocol.(At 40 weeks and 104 weeks)

Similar Trials